The U.S. Food and Drug Administration granted tentative approval to Dr. Reddy’s Laboratories for a generic HIV prevention drug, paving the way for broader global access. Priced at just $40 per person annually, shipments of the preventative shot will begin next month with the backing of international health groups. On the manufacturing side, Lonza is acquiring five U.S. production facilities from Merck KGaA, which is divesting the sites to concentrate on drug development. This major acquisition broadens Lonza's footprint across four states to support advanced cancer and gene therapy output.
Key points
Tentative regulatory clearance will expand affordable preventative HIV options to dozens…: Tentative regulatory clearance will expand affordable preventative HIV options to dozens of low- and middle-income countries.
The multi-site acquisition more than doubles Lonza's manufacturing presence in the United…: The multi-site acquisition more than doubles Lonza's manufacturing presence in the United States to nine total facilities.
The facility transfer allows Merck KGaA to focus resources on drug development while boos…: The facility transfer allows Merck KGaA to focus resources on drug development while boosting Lonza's gene and cancer therapy production.
Sources checked by our analysis pipeline: 1
Top of the morning to you. And a fine one it is here at the Pharmalot campus, where the official mascots are snoozing away and a breathtaking autumn landscape is visible in all directions. Moreover, a warm and shiny sun is making a welcome appearance. To celebrate, yes, we are downing a cup of stimulation — hot buttered rum is our preference today. Feel free to join us. As always, here are your tidbits. Hope your day goes well and you conquer the world. …
After months of anticipation, the U.S. Food and Drug Administration gave tentative approval to Dr. Reddy’s Laboratories to make a generic version of a groundbreaking HIV prevention medicine, a key step in widening access for dozens of low- and middle-income countries, STAT says. The company, one of the world’s largest generic drugmakers, plans to start shipping the medicine next month as part of an effort propelled, in part, by several global health organizations to ensure the drug becomes available in lower-income countries as quickly as possible. The annual cost per person will be $40, comparable…
Rio Tinto is funding a major ecological barrier to shield Western Australia's Pilbara region from an advancing wave of toxic cane toads. The intervention seeks to protect vulnerable endemic species like the northern quoll while helping the mining giant repair community relations following past cultural site destruction. By restricting the invasive pests from accessing vital water sources, the collaborative initiative aims to halt a decades-long ecological crisis.
Hampshire police launched an investigation after an unknown group gained entry to an event on Park Road in Chandler's Ford. The violent incident left five young people injured, with one victim still fighting for his life in critical condition. Authorities are questioning multiple underage suspects as they work to establish the circumstances surrounding the targeted attack.
The fatal on-pitch collision in Spain's second tier has placed Andorra's 25-year-old shot-stopper at the center of both sporting and potential legal repercussions. Following the stoppage-time incident that claimed the life of Tenerife forward Jesus de Miguel, authorities and football governing bodies must determine the severity of formal sanctions. Meanwhile, the Equatorial Guinea international has become the target of widespread condemnation and online abuse.